An mRNA Vaccine Expressing Blood-Stage Malaria Antigens Induces Complete Protection Against Lethal <i>Plasmodium yoelii</i>
Background and Objectives: To evaluate the mRNA vaccine platform for blood-stage <i>Plasmodium</i> parasites, we completed a proof-of-concept study using the <i>P. yoelii</i> mouse model of malaria and two mRNA-based vaccines. Both encoded <i>Py</i>MSP1<sub>...
Saved in:
Main Authors: | Amy C. Ott, Patrick J. Loll, James M. Burns |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/13/7/702 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Red pulp macrophages clear parasites, while marginal metallophilic and marginal zone macrophages support CD4+ T cell activation during Plasmodium yoelii infection
by: Julia Falkenstein, et al.
Published: (2025-07-01) -
EPIDEMIOLOGICAL, CLINICAL AND LABORATORY FEATURES OF IMPORTED MALARIA IN THE NORTH-WEST FEDERAL DISTRICT
by: K. E. Novak, et al.
Published: (2017-04-01) -
GCN5 Is a Master Regulator of Gene Expression in the Malaria Parasite <i>Plasmodium falciparum</i>
by: Amuza Byaruhanga Lucky, et al.
Published: (2025-06-01) -
Plasmodium Ovale Malaria: Endemic Areas in Indonesia
by: Umar Zein, et al.
Published: (2023-03-01) -
Anti-Infective Properties, Cytotoxicity, and <i>In Silico</i> ADME Parameters of Novel 4′-(Piperazin-1-yl)benzanilides
by: Theresa Hermann, et al.
Published: (2025-07-01)